These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37399248)

  • 41. Clonal hematopoiesis in hematological disorders: Three different scenarios.
    Swierczek S; Prchal JT
    Exp Hematol; 2020 Mar; 83():57-65. PubMed ID: 32007480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic Options.
    Iurlo A; Cattaneo D; Gianelli U
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single-Cell DNA Sequencing Reveals Punctuated and Gradual Clonal Evolution in Hepatocellular Carcinoma.
    Guo L; Yi X; Chen L; Zhang T; Guo H; Chen Z; Cheng J; Cao Q; Liu H; Hou C; Qi L; Zhu Z; Liu Y; Kong R; Zhang C; Zhou X; Zhang Z; Song T; Xue R; Zhang N
    Gastroenterology; 2022 Jan; 162(1):238-252. PubMed ID: 34481846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies.
    Puda A; Milosevic JD; Berg T; Klampfl T; Harutyunyan AS; Gisslinger B; Rumi E; Pietra D; Malcovati L; Elena C; Doubek M; Steurer M; Tosic N; Pavlovic S; Guglielmelli P; Pieri L; Vannucchi AM; Gisslinger H; Cazzola M; Kralovics R
    Am J Hematol; 2012 Mar; 87(3):245-50. PubMed ID: 22190018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MLL-PTD in a 13-year-old patient with blast phase myeloproliferative neoplasm: A case report.
    He Z; Wang B; Chen L; Huang Y; Wang H; Yang M; Xiao X; Lu Y; Chen J; Wu Y
    Medicine (Baltimore); 2018 Nov; 97(46):e13220. PubMed ID: 30431598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leukemic Transformation in Myeloproliferative Neoplasms: A Literature Review on Risk, Characteristics, and Outcome.
    Yogarajah M; Tefferi A
    Mayo Clin Proc; 2017 Jul; 92(7):1118-1128. PubMed ID: 28688466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular characterization of triple-negative myeloproliferative neoplasms by next-generation sequencing.
    Maddali M; Venkatraman A; Kulkarni UP; Mani S; Raj S; Sigamani E; Korula A; A FN; Lionel SA; Selvarajan S; Manipadam MT; Abraham A; George B; Mathews V; Balasubramanian P
    Ann Hematol; 2022 Sep; 101(9):1987-2000. PubMed ID: 35840818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of HMGA2 in the proliferation and expansion of a hematopoietic cell in myeloproliferative neoplasms.
    Ikeda K; Ogawa K; Takeishi Y
    Fukushima J Med Sci; 2012; 58(2):91-100. PubMed ID: 23237864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transformation of a chronic myeloproliferative neoplasm to acute myelogenous leukemia: does anything work?
    Kundranda MN; Tibes R; Mesa RA
    Curr Hematol Malig Rep; 2012 Mar; 7(1):78-86. PubMed ID: 22170483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How I treat the blast phase of Philadelphia chromosome-negative myeloproliferative neoplasms.
    Odenike O
    Blood; 2018 Nov; 132(22):2339-2350. PubMed ID: 30333119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome.
    Nikolaev SI; Santoni F; Vannier A; Falconnet E; Giarin E; Basso G; Hoischen A; Veltman JA; Groet J; Nizetic D; Antonarakis SE
    Blood; 2013 Jul; 122(4):554-61. PubMed ID: 23733339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular Pathogenesis of Myeloproliferative Neoplasms.
    Rolles B; Mullally A
    Curr Hematol Malig Rep; 2022 Dec; 17(6):319-329. PubMed ID: 36336766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape.
    Maslah N; Benajiba L; Giraudier S; Kiladjian JJ; Cassinat B
    Leukemia; 2023 May; 37(5):957-963. PubMed ID: 37002477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. QuantumClone: clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction.
    Deveau P; Colmet Daage L; Oldridge D; Bernard V; Bellini A; Chicard M; Clement N; Lapouble E; Combaret V; Boland A; Meyer V; Deleuze JF; Janoueix-Lerosey I; Barillot E; Delattre O; Maris JM; Schleiermacher G; Boeva V
    Bioinformatics; 2018 Jun; 34(11):1808-1816. PubMed ID: 29342233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma.
    Chicard M; Colmet-Daage L; Clement N; Danzon A; Bohec M; Bernard V; Baulande S; Bellini A; Deveau P; Pierron G; Lapouble E; Janoueix-Lerosey I; Peuchmaur M; Corradini N; Defachelles AS; Valteau-Couanet D; Michon J; Combaret V; Delattre O; Schleiermacher G
    Clin Cancer Res; 2018 Feb; 24(4):939-949. PubMed ID: 29191970
    [No Abstract]   [Full Text] [Related]  

  • 56. Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia.
    Albertí-Servera L; Demeyer S; Govaerts I; Swings T; De Bie J; Gielen O; Brociner M; Michaux L; Maertens J; Uyttebroeck A; De Keersmaecker K; Boeckx N; Segers H; Cools J
    Blood; 2021 Feb; 137(6):801-811. PubMed ID: 32812017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blast Phase of Myeloproliferative Neoplasm Resembles Acute Myeloid Leukemia, Myelodysplasia-Related, in Clinical Presentation, Cytogenetic Pattern, and Genomic Profile, and Often Undergoes Reversion to Second Chronic Phase Status After Induction Chemotherapy.
    Zhao Y; Siddiqi I; Wildes TJ; Charles D; Deak K; Wang E
    Arch Pathol Lab Med; 2024 Mar; ():. PubMed ID: 38426696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ASXL1 mutation in clonal hematopoiesis.
    Fujino T; Kitamura T
    Exp Hematol; 2020 Mar; 83():74-84. PubMed ID: 31945396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New mutations and pathogenesis of myeloproliferative neoplasms.
    Vainchenker W; Delhommeau F; Constantinescu SN; Bernard OA
    Blood; 2011 Aug; 118(7):1723-35. PubMed ID: 21653328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms.
    Abdel-Wahab O; Tefferi A; Levine RL
    Hematol Oncol Clin North Am; 2012 Oct; 26(5):1053-64. PubMed ID: 23009937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.